Daiichi Sankyo: Quizartinib launched in Europe to treat AML
ADC评论
August 25, 2022
On August 23, Daiichi Sankyo announced that the European Medicines Agency (EMA) has completed the marketing authorization validation of Quizartinib for the treatment of adults
